Hims & Hers Health Surges to 61st in Market Rankings with $949 Million Turnover

On April 28, 2025, Hims & Hers Health (HIMS) saw a significant surge in trading volume, with a total turnover of $949 million, marking a 147.85% increase from the previous day. This substantial rise placed HIMS at the 61st position in the day's stock market rankings, reflecting a notable 1.39% increase in its stock price.

Analysts anticipate that Hims & Hers Health will report quarterly earnings of $0.14 per share in its upcoming earnings report, indicating a year-over-year increase of 180%. This projection underscores the company's strong financial performance and growth potential.

Hims & Hers Health is also attracting attention from investors due to its high-growth prospects. The company's stock is being closely watched by those looking to capitalize on its potential for significant returns. The earnings forecast for the next quarter is estimated to be $0.12 per share, with a range of $0.06 to $0.16, reflecting a positive outlook for the company's financial performance.

Six analysts have revised their earnings estimates upwards in the last 60 days, contributing to an increase in the Zacks Consensus Estimate to $4.23 per share for 2026. This upward revision highlights the growing confidence in Hims & Hers Health's ability to deliver strong financial results.